“It was complete chaos.” — Wajiha Jurdi Kheir, MD, an ophthalmologist at American University of Beirut Medical Center, describing her experience treating patients after last year’s blast at the nearby Port of Beirut in Lebanon.
“We’ve had this flat ‘there’s no evidence boosters are indicated’ message. The messaging should be, ‘yes, we’re going to need boosters.'” — Robert Schooley, MD, of the University of California San Diego, on the need for a third dose of the COVID-19 vaccine.
“I think we’re going to see a turnaround.” — Anthony Fauci, MD, chief medical advisor to President Biden, on how he anticipates America’s pandemic trajectory to mirror the U.K.’s, especially if vaccination rates continue to improve.
“As in all patients, balancing medication risks with benefits should be individualized to provide the safest effective treatment.” — Russell Cohen, MD, of the University of Chicago, commenting on a study that examined the effectiveness of two biologics for ulcerative colitis.
“Addiction is a stigmatized, confounding illness as well, and people don’t feel comfortable getting involved.” — Marvin Seppala, MD, an addiction specialist and chief medical officer at Hazelden Betty Ford Foundation, on some of the reasons why nurse enrollment in rehabilitation programs is so low.
“This was an ambitious study in a vulnerable population where diabetes management can be challenging due to the risks of high and low glucose associated with kidney failure and dialysis.” — Charlotte Boughton, MD, PhD, of University of Cambridge Metabolic Research Laboratories, discussing the benefits of an artificial pancreas for patients with type 2 diabetes on dialysis.